Jeremiah Altman, PA
Surgical · Connellsville, PANPI 1871791087
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.9% of the total across 293 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,539 and has fallen 62.7% since, to $573 in 2025. Among surgical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 293 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Collegium Pharmaceutical, Inc.$977
- Medtronic$787
- Abbott$406
- Scilex Pharmaceuticals Inc.$251
- Redhill Biopharma Inc.$220
- plus $1K from 19 others
What the payments were for
- Travel & lodging$4629%
- Food & beverage$4,59591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 96 | $1,211 |
| Collegium Pharmaceutical, Inc. | 73 | $977 |
| Medtronic | 8 | $787 |
| Abbott | 9 | $406 |
| Scilex Pharmaceuticals Inc. | 15 | $251 |
| Redhill Biopharma Inc. | 21 | $220 |
| Valinor Pharma, LLC | 10 | $189 |
| Amgen | 14 | $138 |
| Virtus Pharmaceuticals LLC | 7 | $132 |
| Biodelivery Sciences International, Inc. | 10 | $125 |
| AbbVie | 5 | $99 |
| Averitas Pharma Inc. | 3 | $83 |
| Tersera Therapeutics LLC | 3 | $74 |
| Arbor Pharmaceuticals, Inc. | 3 | $59 |
| Boston Scientific | 2 | $54 |
| Protega Pharmaceutials Inc | 3 | $46 |
| Nalu Medical, Inc. | 2 | $36 |
| Tonix Medicines, Inc. | 1 | $33 |
| Pfizer | 2 | $26 |
| GRT US Holding, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $20 |
| Si-bone, Inc. | 1 | $19 |
| Vertex | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Relievant Medsystems, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$432
- VECTRIS$139
How this compares
$5,057 in reported general payments places this provider in the 95th percentile of 626 surgical providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 338 | $173,521 |
| RelistorMethylnaltrexone Bromide | 30 | $92,690 |
| OxycontinOxycodone Hcl | 103 | $70,730 |
| BelbucaBuprenorphine Hcl | 65 | $41,511 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,402 | $31,311 |
| MovantikNaloxegol Oxalate | 72 | $30,157 |
| SymproicNaldemedine Tosylate | 70 | $29,799 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,358 | $24,272 |
| Morphine Sulfate ErMorphine Sulfate | 835 | $19,534 |
| Naloxone Hcl | 175 | $12,965 |
| Fentanyl | 155 | $11,751 |
| LyricaPregabalin | 13 | $11,040 |
| Diclofenac Sodium | 425 | $10,861 |
| Buprenorphine | 52 | $8,849 |
| Gabapentin | 744 | $7,094 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $977 | $215,032403 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,211 | $92,69030 claims |
| Redhill Biopharma Inc.Movantik | $220 | $30,15772 claims |
| Hikma Pharmaceuticals USABuprenorphine, Kloxxado, Morphine Sulfate | $16 | $12,243138 claims |
| PfizerLyrica | $26 | $11,04013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 626 surgical providers in Pennsylvania.
Other surgical in Connellsville
- Patsy SkablaWynnewood$188K
- Kyle LangstonAllentown$50K
- Aaron MacoskeyPittsburgh$40K
- Elissa CastorPittsburgh$25K
- Amanda YakobitisWynnewood$24K
- Dustin HobbsWilkes Barre$15K
- Leah KovalPittsburgh$13K
- Maureen SchullerLancaster$12K
- Margaryta TolchynskaMedia$11K
- Dino SacchettiDickson City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.